Visual-spatial performance deficits in children with neurofibromatosis type-1
Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in vis...
Gespeichert in:
Veröffentlicht in: | American journal of medical genetics 2003-07, Vol.120A (3), p.326-330 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 330 |
---|---|
container_issue | 3 |
container_start_page | 326 |
container_title | American journal of medical genetics |
container_volume | 120A |
creator | Schrimsher, Gregory W. Billingsley, Rebecca L. Slopis, John M. Moore III, Bartlett D. |
description | Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ajmg.a.20048 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73433855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73433855</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</originalsourceid><addsrcrecordid>eNqFkMtP3DAQhy0EAkp744xygVOzjF9r54hWsG1Z4NKXerEmjgOGvLAT0f3vm-0ucIPTzEjf_EbzEXJIYUIB2Cne17cTnDAAobfIPpWSpUJzvv3SM7lHPsR4D8BBquku2aNMcy0l7JOrnz4OWKWxw95jlXQulG2osbEuKVzpre9j4pvE3vmqCK5Jnnx_lzRuCG3p89DW2LfRx6Rfdi6lH8lOiVV0nzb1gPy4OP8--5IubuZfZ2eL1AoOOhUsZ7nkoLjKmZZMaFDAHGau4KWgVhaK5pkah0KXgjGVI81AshyFnFJp-QE5Wed2oX0cXOxN7aN1VYWNa4doFBd89eC7IAOtMj6FEfy8Bm1oYwyuNF3wNYaloWBWns3Ks0Hz3_OIH21yh7x2xSu8ETsCxxsAo8WqDKNRH185kXEt-CqIr7knX7nlm0fN2ber-fP5dL3lY-_-vmxheDDTUao0v67n5ne2uMzYnwuz4P8AWnmkwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20879360</pqid></control><display><type>article</type><title>Visual-spatial performance deficits in children with neurofibromatosis type-1</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schrimsher, Gregory W. ; Billingsley, Rebecca L. ; Slopis, John M. ; Moore III, Bartlett D.</creator><creatorcontrib>Schrimsher, Gregory W. ; Billingsley, Rebecca L. ; Slopis, John M. ; Moore III, Bartlett D.</creatorcontrib><description>Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.</description><identifier>ISSN: 1552-4825</identifier><identifier>ISSN: 0148-7299</identifier><identifier>EISSN: 1552-4833</identifier><identifier>EISSN: 1096-8628</identifier><identifier>DOI: 10.1002/ajmg.a.20048</identifier><identifier>PMID: 12838550</identifier><identifier>CODEN: AJMGDA</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Analysis of Variance ; Attention Deficit Disorder with Hyperactivity - genetics ; Attention Deficit Disorder with Hyperactivity - physiopathology ; attention deficit-hyperactivity disorder ; Biological and medical sciences ; Child ; children ; Dermatology ; Female ; Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue ; Humans ; Male ; Medical sciences ; Neurofibromatosis 1 - genetics ; Neurofibromatosis 1 - physiopathology ; neurofibromatosis type-1 ; Neurology ; Psychomotor Performance - physiology ; Spatial Behavior - physiology ; Tumors of the nervous system. Phacomatoses ; visual-motor ; visual-spatial</subject><ispartof>American journal of medical genetics, 2003-07, Vol.120A (3), p.326-330</ispartof><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><rights>2003 INIST-CNRS</rights><rights>Copyright 2003 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</citedby><cites>FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.20048$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.20048$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14938438$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12838550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schrimsher, Gregory W.</creatorcontrib><creatorcontrib>Billingsley, Rebecca L.</creatorcontrib><creatorcontrib>Slopis, John M.</creatorcontrib><creatorcontrib>Moore III, Bartlett D.</creatorcontrib><title>Visual-spatial performance deficits in children with neurofibromatosis type-1</title><title>American journal of medical genetics</title><addtitle>Am. J. Med. Genet</addtitle><description>Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.</description><subject>Analysis of Variance</subject><subject>Attention Deficit Disorder with Hyperactivity - genetics</subject><subject>Attention Deficit Disorder with Hyperactivity - physiopathology</subject><subject>attention deficit-hyperactivity disorder</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>children</subject><subject>Dermatology</subject><subject>Female</subject><subject>Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurofibromatosis 1 - genetics</subject><subject>Neurofibromatosis 1 - physiopathology</subject><subject>neurofibromatosis type-1</subject><subject>Neurology</subject><subject>Psychomotor Performance - physiology</subject><subject>Spatial Behavior - physiology</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>visual-motor</subject><subject>visual-spatial</subject><issn>1552-4825</issn><issn>0148-7299</issn><issn>1552-4833</issn><issn>1096-8628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtP3DAQhy0EAkp744xygVOzjF9r54hWsG1Z4NKXerEmjgOGvLAT0f3vm-0ucIPTzEjf_EbzEXJIYUIB2Cne17cTnDAAobfIPpWSpUJzvv3SM7lHPsR4D8BBquku2aNMcy0l7JOrnz4OWKWxw95jlXQulG2osbEuKVzpre9j4pvE3vmqCK5Jnnx_lzRuCG3p89DW2LfRx6Rfdi6lH8lOiVV0nzb1gPy4OP8--5IubuZfZ2eL1AoOOhUsZ7nkoLjKmZZMaFDAHGau4KWgVhaK5pkah0KXgjGVI81AshyFnFJp-QE5Wed2oX0cXOxN7aN1VYWNa4doFBd89eC7IAOtMj6FEfy8Bm1oYwyuNF3wNYaloWBWns3Ks0Hz3_OIH21yh7x2xSu8ETsCxxsAo8WqDKNRH185kXEt-CqIr7knX7nlm0fN2ber-fP5dL3lY-_-vmxheDDTUao0v67n5ne2uMzYnwuz4P8AWnmkwQ</recordid><startdate>20030730</startdate><enddate>20030730</enddate><creator>Schrimsher, Gregory W.</creator><creator>Billingsley, Rebecca L.</creator><creator>Slopis, John M.</creator><creator>Moore III, Bartlett D.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20030730</creationdate><title>Visual-spatial performance deficits in children with neurofibromatosis type-1</title><author>Schrimsher, Gregory W. ; Billingsley, Rebecca L. ; Slopis, John M. ; Moore III, Bartlett D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Analysis of Variance</topic><topic>Attention Deficit Disorder with Hyperactivity - genetics</topic><topic>Attention Deficit Disorder with Hyperactivity - physiopathology</topic><topic>attention deficit-hyperactivity disorder</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>children</topic><topic>Dermatology</topic><topic>Female</topic><topic>Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurofibromatosis 1 - genetics</topic><topic>Neurofibromatosis 1 - physiopathology</topic><topic>neurofibromatosis type-1</topic><topic>Neurology</topic><topic>Psychomotor Performance - physiology</topic><topic>Spatial Behavior - physiology</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>visual-motor</topic><topic>visual-spatial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schrimsher, Gregory W.</creatorcontrib><creatorcontrib>Billingsley, Rebecca L.</creatorcontrib><creatorcontrib>Slopis, John M.</creatorcontrib><creatorcontrib>Moore III, Bartlett D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of medical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schrimsher, Gregory W.</au><au>Billingsley, Rebecca L.</au><au>Slopis, John M.</au><au>Moore III, Bartlett D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual-spatial performance deficits in children with neurofibromatosis type-1</atitle><jtitle>American journal of medical genetics</jtitle><addtitle>Am. J. Med. Genet</addtitle><date>2003-07-30</date><risdate>2003</risdate><volume>120A</volume><issue>3</issue><spage>326</spage><epage>330</epage><pages>326-330</pages><issn>1552-4825</issn><issn>0148-7299</issn><eissn>1552-4833</eissn><eissn>1096-8628</eissn><coden>AJMGDA</coden><abstract>Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12838550</pmid><doi>10.1002/ajmg.a.20048</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-4825 |
ispartof | American journal of medical genetics, 2003-07, Vol.120A (3), p.326-330 |
issn | 1552-4825 0148-7299 1552-4833 1096-8628 |
language | eng |
recordid | cdi_proquest_miscellaneous_73433855 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Analysis of Variance Attention Deficit Disorder with Hyperactivity - genetics Attention Deficit Disorder with Hyperactivity - physiopathology attention deficit-hyperactivity disorder Biological and medical sciences Child children Dermatology Female Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue Humans Male Medical sciences Neurofibromatosis 1 - genetics Neurofibromatosis 1 - physiopathology neurofibromatosis type-1 Neurology Psychomotor Performance - physiology Spatial Behavior - physiology Tumors of the nervous system. Phacomatoses visual-motor visual-spatial |
title | Visual-spatial performance deficits in children with neurofibromatosis type-1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A36%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual-spatial%20performance%20deficits%20in%20children%20with%20neurofibromatosis%20type-1&rft.jtitle=American%20journal%20of%20medical%20genetics&rft.au=Schrimsher,%20Gregory%20W.&rft.date=2003-07-30&rft.volume=120A&rft.issue=3&rft.spage=326&rft.epage=330&rft.pages=326-330&rft.issn=1552-4825&rft.eissn=1552-4833&rft.coden=AJMGDA&rft_id=info:doi/10.1002/ajmg.a.20048&rft_dat=%3Cproquest_cross%3E73433855%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20879360&rft_id=info:pmid/12838550&rfr_iscdi=true |